Table 3. Risk of acetaminophen and ibuprofen use in subgroups of children, female children, and male children with asthma.
| (A) Risk of acetaminophen and ibuprofen use in subgroups of children with asthma | ||||||||
|---|---|---|---|---|---|---|---|---|
| Antipyretics | Without asthma exacerbation in the previous year | Asthma exacerbation in the previous year | ||||||
| Asthma exacerbation | Adjusted OR | Asthma exacerbation | Adjusted OR | |||||
| No (%) | Yes (%) | (95% CI) | P-value | No (%) | Yes (%) | (95% CI) | P-value | |
| Acetaminophen | 506 (97.3) | 14 (2.7) | Reference | 58 (81.7) | 13 (18.3) | Reference | ||
| Ibuprofen | 340 (95.8) | 15 (4.2) | 1.52 [0.71–3.25] | 0.28 | 22 (59.5) | 15 (40.5) | 3.28 [1.30–8.29] | 0.01 |
Notes:
Model adjusted for age, sex, and patient status in the previous year (AE and use of systemic corticosteroids).
OR, odds ratios; CI, confidence intervals.